Paper40765830
New insights into coordinated regulation of AHR promoter transcription; molecular mechanisms and therapeutic targets.
Wuputra K and 10 others. Int J Biol Sci, 2025. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. New insights into coordinated regulation of AHR promoter transcription; molecular mechanisms and therapeutic targets. Papers, record 40765830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40765830
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- New insights into coordinated regulation of AHR promoter transcription; molecular mechanisms and therapeutic targets.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Aryl Hydrocarbon | Major topic |
| Promoter Regions, Genetic | Major topic |
| Transcription, Genetic | Major topic |
| Humans | |
| NF-E2-Related Factor 2 | |
| Animals | |
| Reactive Oxygen Species | |
| Signal Transduction |
Source PubMed
References248
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32915464 | Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells. | EMBO J | 2020 | https://conductscience.org/library/papers/32915464 | PubMed |
| 2 | 17590016 | Multiple roles for acetylation in the interaction of p300 HAT with ATF-2. | Biochemistry | 2007 | https://conductscience.org/library/papers/17590016 | PubMed |
| 3 | 34666225 | Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. | EBioMedicine | 2021 | https://conductscience.org/library/papers/34666225 | PubMed |
| 4 | 31672612 | Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions. | Biochim Biophys Acta Mol Cell Res | 2020 | https://conductscience.org/library/papers/31672612 | PubMed |
| 5 | 8943040 | NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8943040 | PubMed |
| 6 | 35461154 | Increased risk of cancer mortality by smoking-induced aryl hydrocarbon receptor repressor DNA hypomethylation in Japanese population: A long-term cohort study. | Cancer Epidemiol | 2022 | https://conductscience.org/library/papers/35461154 | PubMed |
| 7 | 10644764 | Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10644764 | PubMed |
| 8 | 15858847 | Nuclear receptors and drug disposition gene regulation. | J Pharm Sci | 2005 | https://conductscience.org/library/papers/15858847 | PubMed |
| 9 | 24658119 | 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex. | PLoS One | 2014 | https://conductscience.org/library/papers/24658119 | PubMed |
| 10 | 21496237 | Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. | J Exp Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21496237 | PubMed |
| 11 | 34523522 | Associations of polycyclic aromatic hydrocarbons exposure and its interaction with XRCC1 genetic polymorphism with lung cancer: A case-control study. | Environ Pollut | 2021 | https://conductscience.org/library/papers/34523522 | PubMed |
| 12 | 18772891 | Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. | Nature | 2008 | https://conductscience.org/library/papers/18772891 | PubMed |
| 13 | 22197621 | BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells. | J Nutr Biochem | 2012 | https://conductscience.org/library/papers/22197621 | PubMed |
| 14 | 27599530 | HDACs and HDAC Inhibitors in Cancer Development and Therapy. | Cold Spring Harb Perspect Med | 2016 | https://conductscience.org/library/papers/27599530 | PubMed |
| 15 | 12203118 | Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. | Oncogene | 2002 | https://conductscience.org/library/papers/12203118 | PubMed |
| 16 | 15123765 | Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. | J Pharmacol Exp Ther | 2004 | https://conductscience.org/library/papers/15123765 | PubMed |
| 17 | 34499523 | Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor. | Annu Rev Pharmacol Toxicol | 2022 | https://conductscience.org/library/papers/34499523 | PubMed |
| 18 | 22770212 | Cancer epigenetics: from mechanism to therapy. | Cell | 2012 | https://conductscience.org/library/papers/22770212 | PubMed |
| 19 | 39890034 | Aryl hydrocarbon receptor (AHR) and nuclear factor erythroid-derived 2-like 2 (NRF2): An important crosstalk in the gut-liver axis. | Biochem Pharmacol | 2025 | https://conductscience.org/library/papers/39890034 | PubMed |
| 20 | 40303302 | The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40303302 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42505552 | AhR as a Common Denominator in Immunity and Inflammation in Chronic Lung Diseases: Molecular and Clinical Insights. | Diseases | 2026 | https://conductscience.org/library/papers/42505552 | PubMed |
| 41939772 | The microbiota-gut-brain-epigenome axis as a novel therapeutic target for decoding postpartum depression. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41939772 | PubMed |
| 41588481 | Therapeutic Potential of Resveratrol in Cancer and Neurodegenerative Disorders: A Current Review. | Biofactors | 2026 | https://conductscience.org/library/papers/41588481 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AHR | 196 | PubTator's text mining | https://conductscience.org/library/genes/196 | NCBI Gene |
| JDP2 | 122953 | PubTator's text mining | https://conductscience.org/library/genes/122953 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40765830
GET https://conductscience.org/api/papers/v1/40765830/references?page=2